STOCK TITAN

Solitron Devices (SODI) director privately sells 8,000 shares at $28.50

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Solitron Devices Inc. director John F. Chiste reported a sale of 8,000 shares of common stock on 2026-08-14 at $28.50 per share in a private agreement with Allens Creek Partners LP. The transaction reduced his directly held common stock position to zero shares, and the shares retain an affiliate restriction after the sale.

Positive

  • None.

Negative

  • None.
Insider CHISTE JOHN F
Role Director
Sold 8,000 shs ($228K)
Type Security Shares Price Value
Sale Common stock F1 8,000 $28.50 $228K
Holdings After Transaction: Common stock — 0 shares (Direct)
Footnotes (1)
  1. F1. Mr. Chiste sold these shares through a private agreement with Allens Creek Partners LP. The sale price was agreed to prior to the sale date and subsequent price change. Eriksen Capital Management LLC ("ECM"), managed by Tim Eriksen, Solitron's CEO, has a sub-advisory agreement with Allens Creek. Shares retain an affiliate restriction after the sale.
Shares sold 8,000 shares Common stock sold by director John F. Chiste on 2026-08-14
Sale price per share $28.50 per share Price for Solitron Devices common stock in the private sale
Shares held after transaction 0 shares Directly held Solitron Devices common stock following the sale
affiliate restriction regulatory
"Shares retain an affiliate restriction after the sale"
sub-advisory agreement financial
"Eriksen Capital Management LLC has a sub-advisory agreement with Allens Creek"
A sub-advisory agreement is a contract in which the primary investment manager of a fund or portfolio hires a separate, specialist firm to manage some or all of the assets. For investors this matters because it can change who actually makes trading and strategy decisions, how fees are split, and how performance and risk are handled—similar to a homeowner hiring a specialist contractor who may yield different results than the main builder.
private agreement financial
"sold these shares through a private agreement with Allens Creek Partners LP"

FAQ

What insider transaction did Solitron Devices (SODI) disclose for John F. Chiste?

Solitron Devices disclosed that director John F. Chiste sold 8,000 shares of common stock on 2026-08-14. The shares were sold at $28.50 per share through a private agreement with Allens Creek Partners LP and retain an affiliate restriction after the sale.

At what price were the Solitron Devices (SODI) shares sold in John F. Chiste’s Form 4 filing?

The reported sale price was $28.50 per share for 8,000 shares of Solitron Devices common stock. The footnote states this price was agreed to before the sale date and before a subsequent price change, in a private agreement with Allens Creek Partners LP.

How many Solitron Devices (SODI) shares does John F. Chiste hold after this reported sale?

After the reported transaction, John F. Chiste’s directly held Solitron Devices common stock position is 0 shares. The Form 4 shows 8,000 shares sold and a total of 0 shares following the transaction, indicating this sale fully exited his direct common stock holdings.

What does the Form 4 footnote reveal about Allens Creek Partners LP and Solitron Devices (SODI)?

The footnote explains that Allens Creek Partners LP purchased the 8,000 shares via a private agreement at $28.50 per share. Eriksen Capital Management LLC, managed by Solitron’s CEO Tim Eriksen, has a sub-advisory agreement with Allens Creek, and the shares retain an affiliate restriction after the sale.

Was John F. Chiste’s Solitron Devices (SODI) sale under a Rule 10b5-1 trading plan?

The Form 4’s Rule 10b5-1 checkbox is not marked as an affirmative plan, and the footnote instead notes a privately negotiated sale with Allens Creek Partners LP. The price was agreed to before the sale date and a subsequent price change.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CHISTE JOHN F

(Last)(First)(Middle)
C/O SOLITRON DEVICES, INC.
901 SANSBURYS WAY

(Street)
WEST PALM BEACH FLORIDA 33411

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SOLITRON DEVICES INC [ SODI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock08/14/2026S8,000(1)D$28.50D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Mr. Chiste sold these shares through a private agreement with Allens Creek Partners LP. The sale price was agreed to prior to the sale date and subsequent price change. Eriksen Capital Management LLC ("ECM"), managed by Tim Eriksen, Solitron's CEO, has a sub-advisory agreement with Allens Creek. Shares retain an affiliate restriction after the sale.
/s/ John F Chiste08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)